Coronary Artery Disease Therapeutics Market to Witness A Pronounce Growth During 2024-2031 | Novartis, Pfizer, Bayer, Merck & Co, Glaxo Smith Kline

Market Overview:

Coronary artery disease therapeutics are used for the treatment of coronary artery disease, also known as ischemic heart disease. It involves the narrowing or blockage of the coronary arteries due to plaque buildup inside the arteries. The main products used are drugs, devices, and cell therapies.

Market Dynamics:

The coronary artery disease therapeutics market is expected to grow owing to rising geriatric population across the globe who are more susceptible to cardiovascular diseases. As per the United Nations report, the population aged 60 years and above is projected to grow from 10% to 22% globally between 2014 and 2050. Additionally, growing prevalence of coronary artery diseases due to sedentary lifestyles and increasing consumption of tobacco and alcoholic beverages is also expected to propel the market growth during the forecast period.

Request Sample Copy of the Report at: - https://www.coherentmarketinsights.com/insight/request-sample/1799

List of TOP Players in Market Report are: -

◘ Astra Zeneca
◘ Gilead
◘ Novartis
◘ Pfizer
◘ Bayer
◘ Merck & Co
◘ Glaxo Smith Kline
◘ Mylan N.V.

Market Detailed Segmentation:

By Drug Type:-

Beta Blockers
Calcium Channel Blockers
ACE Inhibitors
Nitrates
Statin
Others

By Distribution Channel:-

Hospitals
Online Pharmacies
Retail Pharmacies

The emergence of advanced treatment options driving the Coronary Artery Disease Therapeutics Market

The coronary artery disease therapeutics market has witnessed tremendous growth in the last decade due to the emergence of technologically advanced treatment options for coronary artery disease. Drug eluting stents have become the standard of care for percutaneous coronary intervention procedures due to their superior efficacy as compared to bare metal stents in reducing restenosis rates. Furthermore, the development of bioabsorbable drug eluting stents is expected to further drive the market as they dissolve safely leaving the artery vessel unaffected. In addition, advancement in catheter and imaging technologies have enabled minimally invasive procedures such as balloon angioplasty to treat narrowing of arteries with high success rates and minimal complications.

Rising healthcare costs act as a market restrain

Healthcare costs associated with coronary artery disease pose a major financial burden. Coronary artery disease therapies including drugs, medical devices, diagnostic tests, hospital stays and rehabilitation incur heavy costs which are ever increasing. High costs of coronary stents, especially drug eluting stents limit their widespread adoption. The costs involved in surgical procedures for coronary artery disease such as coronary artery bypass graft also act as a deterrent. Economic burden of coronary artery disease poses treatment non-affordability which impedes market growth to some extent.

Buy This Premium Report and Get Upto 25 % OFF: https://www.coherentmarketinsights.com/insight/buy-now/1799

Increasing focus on preventive care presents a lucrative market opportunity

Traditionally more focus has been given to treatment of coronary artery disease. However, with growing awareness, preventive strategies are gaining increased attention which opens up new opportunities. Market players are exploring opportunities in developing innovative preventive solutions. Cardioprotective drugs, blood lipid lowering agents, antiplatelet drugs, and lifestyle management programs are emerging as effective prevention strategies. Telecardiology and mHealth solutions also present new avenues to promote preventive care and medical adherence outside hospital settings. The preventive approach can help catch the disease early and save costs associated with advanced treatments.

Shift towards personalized medicine shaping future market trends

Emerging trends suggest future therapies will be more tailored according to individual patient characteristics. Personalized medicine aims to provide right treatment to the right patient at right time. This involves understanding individual patient's genetic makeup, environment, and lifestyle to customize treatment approach. Biomarkers, pharmacogenomics and companion diagnostics are playing a pivotal role in enabling risk prediction and prognosis. Personalized medicine promises improved outcomes through targeted prevention and precision therapies. It also fosters safer and more cost-effective patient care. This emerging trend is well positioned to transform the landscape of coronary artery disease therapeutics market in the future.

Furthermore, the years considered for the study are as follows:

Historical data - 2016-2022
The base year for estimation - is 2022
Estimated Year - 2024
Forecast period** - 2024 to 2031

This Coronary Artery Disease Therapeutics Market Research/Analysis Report Contains Answers to your following Questions:

◈What are the current global trends in the Coronary Artery Disease Therapeutics market, and will the market experience an increase or decrease in demand in the upcoming years?

◈ What is the expected demand for various product types within the Coronary Artery Disease Therapeutics market, and what are the emerging Market applications and trends?

◈ What are the projections for the global Coronary Artery Disease Therapeutics Market in terms of capacity, production, production value, cost, profit, market share, supply, consumption, import, and export?

◈ How will strategic developments shape the Market trajectory in the medium to long term?

◈ What factors contribute to the final price of Coronary Artery Disease Therapeutics , and what are the raw materials used in its manufacturing?

◈ What is the market's growth potential, particularly with the increasing adoption of Coronary Artery Disease Therapeutics in mining?

◈ What is the current and 2022 value of the global market, and who are the leading companies in this market?

◈ What recent Market trends can be leveraged to create additional revenue streams?

◈ What entry strategies, economic impact mitigation measures, and marketing channels should be considered for the Coronary Artery Disease Therapeutics Market?

We Offer Customized Report, Click @ https://www.coherentmarketinsights.com/insight/request-customization/1799

Summarized Extracts from TOC of Market Study

Chapter 1 Coronary Artery Disease Therapeutics Introduction and Market Overview

1.1 Objectives of the Study

1.2 Overview of Coronary Artery Disease Therapeutics

1.3 Scope of The Study

1.3.1 Key Market Segments

1.3.2 Players Covered

1.3.3 COVID-19's impact on the Coronary Artery Disease Therapeutics industry

1.4 Methodology of The Study

1.5 Research Data Source

Chapter 2 Executive Summary

Chapter 3 Industry Chain Analysis

Chapter 4 Market, by Type

Chapter 5 Market, by Application

Chapter 6 Market Analysis by Regions

Chapter 7 North America Market Analysis by Countries

Chapter 8 Europe Coronary Artery Disease Therapeutics Market Analysis by Countries

Chapter 9 Asia Pacific Coronary Artery Disease Therapeutics Market Analysis by Countries

Chapter 10 Middle East and Africa Coronary Artery Disease Therapeutics Market Analysis by Countries

Chapter 11 South America Coronary Artery Disease Therapeutics Market Analysis by Countries

Chapter 12 Competitive Landscape

Chapter 13 Industry Outlook

Chapter 14 Market Forecast

Chapter 15 New Project Feasibility Analysis

Contact Us

Mr. Shah
Coherent Market Insights Pvt Ltd,
533 Airport Boulevard, Suite 400, Burlingame,
CA 94010, United States
Phone: US +12067016702 / UK +4402081334027
JAPAN:+81-50-5539-1737
INDIA:+91-848-285-0837
Email: sales@coherentmarketinsights.com

About Coherent Market Insights

Coherent Market Insights is a global market intelligence and consulting organization that provides syndicated research reports, customized research reports, and consulting services. We are known for our actionable insights and authentic reports in various domains including aerospace and defense, agriculture, food and beverages, automotive, chemicals and materials, and virtually all domains and an exhaustive list of sub-domains under the sun. We create value for clients through our highly reliable and accurate reports. We are also committed in playing a leading role in offering insights in various sectors post-COVID-19 and continue to deliver measurable, sustainable results for our clients.

This release was published on openPR.